Medical Cannabis Regulation Commission Created -Duties

(a)[No text]

(1)There shall be established within the Department of Public Health and Social Services a Medical Cannabis Regulation Commission (Commission) consisting of eleven

(11)members. Commission members shall serve for a term of four

(4)years. Appointments to fill vacancies shall be appointed no later than thirty

(30)calendar days of a resignation or vote of removal of a Commission member by a majority vote of six

(6)votes of the other members of the Commission. CH. 12 MEDICAL PRACTICES - PART II

(2)The members shall elect a chairperson of the Commission to coordinate meetings; and the Commission shall consist of the following members:

(A)the Director of the Department of Public Health and Social Services or his designee;

(B)the Chairperson of the Guam Board of Medical Examiners or his designee;

(C)the Director of the Department of Agriculture or his designee;

(D)the Administrator of the Guam Environmental Protection Agency or his designee;

(E)the Chairperson of the Legislative Committee on Health and Human Services or his designee;

(F)a member of the public at large appointed by I Maga’håga/Maga’låhi;

(G)a member of the public at large appointed by I Liheslatura;

(H)a qualified patient, caregiver, or patient advocate who shall be appointed by the Commission;

(I)a licensed possessor who shall be appointed by the Commission; and

(J)the remaining two

(2)members appointed by the Commission shall be practitioners representing the field of oncology, neurology, psychiatry, or pain management, who shall be board-certified in his or her area of specialty and knowledgeable about the medical use of cannabis.

(3)A quorum of said Commission shall consist of six

(6)members.

(b)The Commission shall:

(1)review and recommend to the DPHSS for approval additional debilitating medical conditions that would benefit from the medical use of cannabis;

(2)accept and review petitions to add medical conditions, medical treatments or diseases to the list of debilitating medical conditions that qualify for the medical use of cannabis;

(3)convene at least twice per year to conduct public hearings and to evaluate petitions (which shall be maintained as confidential personal health information), to add medical conditions, medical treatments or diseases to the list of debilitating medical conditions that qualify for the medical use of cannabis;

(4)recommend quantities of cannabis that are necessary to constitute an allowable amount for qualified patients and primary caregivers;

(5)advise the DPHSS on the development of standards and regulations pursuant to this Article, including best practices and guidelines to ensure qualified patients have adequate access to medical cannabis and medical cannabis products; and

(6)submit policy recommendations to the legislative committee on health and human services.